FDA Approved: DESFERAL — Supplemental Application (MITEM PHARMA)

View source ↗

Summary

The FDA approved a supplemental application for DESFERAL (deferoxamine mesylate) submitted by Mitem Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Iron Poisoning

Drugs mentioned

• Desferal (Deferoxamine Mesylate)

Snippet

SUPPL AP for DESFERAL (DEFEROXAMINE MESYLATE)